7-147395523-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014141.6(CNTNAP2):​c.1499-86C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,298,102 control chromosomes in the GnomAD database, including 14,415 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1523 hom., cov: 32)
Exomes 𝑓: 0.14 ( 12892 hom. )

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.198

Publications

4 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 7-147395523-C-T is Benign according to our data. Variant chr7-147395523-C-T is described in ClinVar as Benign. ClinVar VariationId is 670795.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.304 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1499-86C>T intron_variant Intron 9 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.1499-86C>T intron_variant Intron 9 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1499-86C>T intron_variant Intron 9 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1

Frequencies

GnomAD3 genomes
AF:
0.129
AC:
19601
AN:
151892
Hom.:
1520
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0753
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.190
Gnomad ASJ
AF:
0.136
Gnomad EAS
AF:
0.318
Gnomad SAS
AF:
0.172
Gnomad FIN
AF:
0.160
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.141
GnomAD4 exome
AF:
0.139
AC:
159787
AN:
1146092
Hom.:
12892
AF XY:
0.140
AC XY:
81978
AN XY:
584200
show subpopulations
African (AFR)
AF:
0.0731
AC:
1983
AN:
27136
American (AMR)
AF:
0.232
AC:
10117
AN:
43670
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
3065
AN:
23498
East Asian (EAS)
AF:
0.353
AC:
13336
AN:
37814
South Asian (SAS)
AF:
0.173
AC:
13612
AN:
78668
European-Finnish (FIN)
AF:
0.165
AC:
8462
AN:
51138
Middle Eastern (MID)
AF:
0.209
AC:
1053
AN:
5036
European-Non Finnish (NFE)
AF:
0.122
AC:
101041
AN:
829374
Other (OTH)
AF:
0.143
AC:
7118
AN:
49758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
6612
13224
19837
26449
33061
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3400
6800
10200
13600
17000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.129
AC:
19619
AN:
152010
Hom.:
1523
Cov.:
32
AF XY:
0.134
AC XY:
9954
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.0755
AC:
3134
AN:
41522
American (AMR)
AF:
0.190
AC:
2895
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
471
AN:
3464
East Asian (EAS)
AF:
0.317
AC:
1634
AN:
5150
South Asian (SAS)
AF:
0.172
AC:
829
AN:
4826
European-Finnish (FIN)
AF:
0.160
AC:
1695
AN:
10580
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.125
AC:
8510
AN:
67924
Other (OTH)
AF:
0.141
AC:
297
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
858
1717
2575
3434
4292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
193
Bravo
AF:
0.129
Asia WGS
AF:
0.231
AC:
799
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.8
DANN
Benign
0.49
PhyloP100
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs700308; hg19: chr7-147092615; COSMIC: COSV62186420; API